Joshua Drew will speak at the 19th Annual FCPA & Anti-Corruption for the Life Sciences Industry conference on May 10, 2024. Drew will participate in the panel presentation "Life Science M&A/Joint Ventures: High-Stakes Decision-Making Around DOJ's Safe Harbor Policy, Due Diligence, Privacy, and Post-Transaction Integration." The panel will discuss the Department of Justice's (DOJ's) Merger & Acquisition (M&A) Safe Harbor Policy, including steps to take when you discover Foreign Corrupt Practices Act (FCPA) violations and the benefits of self-disclosure, and risk assessments and asset allocations in spinoff mergers.